×
About 723 results

ALLMedicine™ Membranoproliferative Glomerulonephritis Center

Research & Reviews  271 results

Clinical and histopathologic predictors of recurrent glomerulonephritis after kidney tr...
https://doi.org/10.1111/ctr.14970
Clinical Transplantation; Chukwu CA, Holmberg C et. al.

Mar 24th, 2023 - We evaluated the long-term outcomes of recurrent glomerulonephritis (RGN) using clinical, histopathological, and demographic predictors. A retrospective cohort study of kidney transplant recipients (KTR) in two renal centers between 2005 and 2020....

Diffuse Proliferative Glomerulonephritis
http://emedicine.medscape.com/article/239646-overview

Mar 9th, 2023 - Practice Essentials Diffuse proliferative glomerulonephritis (DPGN) is a term used to describe a distinct histologic form of glomerulonephritis common to various types of systemic inflammatory diseases, including autoimmune disorders (eg, systemic...

Diffuse Proliferative Glomerulonephritis
https://emedicine.medscape.com/article/239646-print

Mar 9th, 2023 - Practice Essentials Diffuse proliferative glomerulonephritis (DPGN) is a term used to describe a distinct histologic form of glomerulonephritis common to various types of systemic inflammatory diseases, including autoimmune disorders (eg, systemic...

Diffuse Proliferative Glomerulonephritis
https://emedicine.medscape.com/article/239646-overview

Mar 9th, 2023 - Practice Essentials Diffuse proliferative glomerulonephritis (DPGN) is a term used to describe a distinct histologic form of glomerulonephritis common to various types of systemic inflammatory diseases, including autoimmune disorders (eg, systemic...

Renal Vein Thrombosis
https://emedicine.medscape.com/article/460752-print

Mar 1st, 2023 - Practice Essentials Renal vein thrombosis (RVT) most commonly occurs in patients with nephrotic syndrome (defined as urinary protein loss >3 g/day, hypoalbuminemia, hypercholesterolemia, and edema) due to the loss of antithrombin III (ATIII) in th...

see more →

Clinicaltrials.gov  9 results

Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis
https://clinicaltrials.gov/ct2/show/NCT05067127

Feb 10th, 2023 - This is a Phase 3 study to assess the efficacy and safety of twice-weekly subcutaneous (SC) doses of pegcetacoplan compared to placebo in patients with C3 glomerulopathy (C3G) or immune-complex membranoproliferative glomerulonephritis (IC-MPGN) on...

Non-contrast Enhanced MRI in Patients With C3 Glomerulopathy (C3G) or Immune-complex Membranoproliferative Glomerulonephritis (IC-MPGN) Enrolled in the ACH471-205 Study
https://clinicaltrials.gov/ct2/show/NCT03723512

Nov 26th, 2021 - Functional and quantitative renal magnetic resonance imaging (MRI) has seen a number of recent advances, and techniques are now available that can generate quantitative imaging biomarkers with the potential to improve the management of kidney dise...

Prevalence of Renal Disease in Children With Celiac Disease
https://clinicaltrials.gov/ct2/show/NCT05049876

Oct 8th, 2021 - In this study the investigators seek to quantify the prevalence of urine sediment abnormalities in children with celiac disease to assess whether there is value in screening for renal disease in this population. Celiac disease (CD) is frequently a...

Eculizumab Therapy for Dense Deposit Disease and C3 Nephropathy
https://clinicaltrials.gov/ct2/show/NCT01221181

Feb 19th, 2019 - Dense deposit disease (DDD), also called membranoproliferative glomerulonephritis (MPGN) type II, is a rare form of glomerulonephritis named because of the characteristic appearance of electron-dense material in the glomerular basement membrane ob...

Chronic Hepatitis C in Chronic Hemodialysis Recipients - An Observational Study
https://clinicaltrials.gov/ct2/show/NCT03461250

Apr 3rd, 2018 - Epidemiological Data It is estimated that chronic infection with the chronic hepatitis C virus (HCV) affects approximately 180 million people worldwide (1). It has surpassed HIV infection as the leading cause of death from viral infection in multi...

see more →

News  9 results

A 58-Year-Old Man With a Rash and Elevated Creatinine Levels
https://reference.medscape.com/viewarticle/919074_4

Oct 2nd, 2019 - Clinicians should have a high index of suspicion for cryoglobulinemia in patients known to have HCV infection who present with nephritic syndrome, proteinuria, or renal dysfunction.[25] HBV and HIV are also associated with cryoglobulinemia; thus, ...

A Rare Case of Immunotactoid Glomerulopathy and Monoclonal Gammopathy of Renal Significance due to an IgM Kappa Clone at the VA Pittsburgh Healthcare System
https://www.mdedge.com/fedprac/avaho/article/207783/mixed-topics/rare-case-immunotactoid-glomerulopathy-and-monoclonal?channel=53
Kuang C, Alshoubaki N et. al.

Sep 9th, 2019 - Introduction: Monoclonal gammopathy of renal significance (MGRS) is a recently recognized disorder from pathologic M protein causing renal disease and minimal hematologic disease burden. Failure to treat leads to poor outcomes from progression to.

A Rare Case of Immunotactoid Glomerulopathy and Monoclonal Gammopathy of Renal Significance due to an IgM Kappa Clone at the VA Pittsburgh Healthcare System
https://www.mdedge.com/fedprac/avaho/article/207783/mixed-topics/rare-case-immunotactoid-glomerulopathy-and-monoclonal
Kuang C, Alshoubaki N et. al.

Sep 9th, 2019 - Introduction: Monoclonal gammopathy of renal significance (MGRS) is a recently recognized disorder from pathologic M protein causing renal disease and minimal hematologic disease burden. Failure to treat leads to poor outcomes from progression to.

A 65-Year-Old Man With Hypertension and Proteinuria
https://reference.medscape.com/viewarticle/852384_3

Oct 12th, 2015 - On the basis of the history, physical examination, and workup, what is the diagnosis? Your Peers Chose: Diabetic kidney disease 0% Hypertensive nephrosclerosis 0% Unrecovered AKI 0% Hepatitis C-related membranoproliferative glomerulonephritis 0% D...

HCV Treatment: What Can I Do Now? What's Coming Next?
https://www.medscape.com/viewarticle/849473_4

Aug 24th, 2015 - Options for Difficult-to-Treat Patients The HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C website[16] provides recommendations for the treatment of patients with decompensated HCV cirrhosis (Child-Turcotte-Pugh clas...

see more →